Importance There is limited information about the relative effectiveness of cervical cancer
screening with primary human papillomavirus (HPV) testing alone compared with cytology in …

Background The success of any COVID-19 vaccine program ultimately depends on high
vaccine uptake. This study determined overall intention to receive a COVID-19 vaccine and …

Complete Round 1 data (baseline and 12‐month follow‐up) for HPV FOCAL, a randomized
trial establishing the efficacy of HPV DNA testing with cytology triage as a primary screen for …

Objectives The SARS-CoV-2 (COVID-19) pandemic has had profound physical and mental
health effects on populations around the world. Limited empirical research has used a gender…

Background In the HPV FOCAL trial, we will establish the efficacy of hr-HPV DNA testing as
a stand-alone screening test followed by liquid based cytology (LBC) triage of hr-HPV-…

Effective approaches to improve coverage of self-collected human papillomavirus (HPV)-based
cervix screening (SCS) as well as attendance at treatment for HPV-positive participants …

COVID-19 vaccination is recommended for people living with HIV (PLWH), among whom
social inequities and co-morbidities may drive risks of COVID-19 infection and outcome severity…

Human papillomavirus (HPV)‐based cervical cancer screening requires triage of HPV
positive women to identify those at risk of cervical intraepithelial neoplasia grade 2 (CIN2) or …

We explored the potential impact of human papillomavirus (HPV) testing on women's intentions
to be screened for cervical cancer in a cohort of Canadian women. Participants aged 25–…

Background High-risk HPV DNA testing has been proposed as a primary tool for cervical
cancer screening (HPV-CCS) as an alternative to the Papanicolaou cytology- method. This …